News

Integrium works with specialty, development-stage, mid-size, and large biopharmaceutical and medical device companies, providing a complete range of clinical trial management services for Phase I through Phase IV

Baxa said that after completion of automated TPN compounding, DoseEdge TPN can help catch and prevent errors in the workflow and processes. The software also includes new safety

As per the agreement American Nano and Technical Institute of Physics and Chemistry of CAS will create a new ultra fne chemistry research center, which is expected to

The products help to prevent the transmission of blood-borne diseases such as HIV and hepatitis C via needlestick injuries, aerosol dispersal and syringe reuse. Primary target markets of

By acquiring the Lab Systems division of Dynacon, a privately held corporation based in Ontario, Canada, BD adds product platforms in preanalytical microbiology automation. The product platforms include

The acquisition is expected to allow the integration of Medpace’s therapeutic expertise and global reach with the device expertise of Symbios to offer clinical trial management solutions to

SAFC said that the new facility complements its existing 63,000 sq ft HPAPI site in Madison and houses commercial scale reactors capable of producing HPAPI batch sizes up

Jantibody Therapeutics was created by Boston BioCom to commercialise a new class of immunologically-enhanced monoclonal antibodies (mAbs) that utilise heat shock protein 70 (HSP 70) for initial applications

BioAlliance Pharma is expected to receive up to EUR48.5m from Therabel, of which EUR6.5m as upfront payments including EUR4.5m at signature and two annual payments of EUR1m each